@tarawoodland_fnp's functional medicine training, fact-checked

What did @tarawoodland_fnp actually say?

Honestly? Nothing reviewable. The transcript reads: "All of boys, you stop. Go battle me. What you know about." That is not a coherent medical statement. It appears to be garbled audio, a background song lyric, or a transcription error, not clinical content about hormones or TRT. There is nothing here to fact-check in the traditional sense.

The caption, however, does tell us something. Tara is an FNP completing a module through the Institute for Functional Medicine, specifically on hormones. She notes she is about three weeks from returning to clinical practice. That context matters, because functional medicine hormone training has a specific ideological and clinical flavor that differs from endocrinology society guidelines, and that distinction is worth examining.

Does the science back this up?

There is no spoken claim to evaluate against the evidence. But we can assess the framing. Functional medicine hormone education often emphasizes "optimization" over treatment of diagnosed deficiency. The evidence base for testosterone optimization in men without confirmed hypogonadism is genuinely thin.

The Testosterone Trials (Snyder et al., 2016, New England Journal of Medicine) showed modest benefits for sexual function and mood in older hypogonadal men, but these were men with confirmed low testosterone, not men seeking optimization. The American Urological Association defines hypogonadism as total testosterone below 300 ng/dL with symptoms. Treating men above that threshold with TRT remains off-label and evidence-limited. For women, testosterone therapy is even less standardized, with the 2019 Global Consensus Position Statement (Davis et al., Menopause) supporting testosterone only for hypoactive sexual desire disorder in postmenopausal women.

What did they get wrong (or right)?

Credit where it is due: completing structured hormone education before practicing in this space is responsible. The Institute for Functional Medicine does offer accredited coursework, and a provider who invests in continuing education before treating patients is doing the right thing, even if the functional medicine framework itself sometimes gets ahead of the evidence.

What raises a flag is not what Tara said in this video but what the category and platform context suggest. TRT content on Instagram frequently conflates optimization with treatment, normalizes testosterone use outside of clinical guidelines, and targets audiences who may self-diagnose. A provider stepping into this space should know that functional medicine hormone protocols often include practices, such as routine pellet therapy or salivary hormone testing, that lack strong evidentiary support. Salivary cortisol testing, for instance, is not validated for diagnosing adrenal insufficiency (Aardal-Eriksson et al., 1998, Scandinavian Journal of Clinical Laboratory Investigation).

What should you actually know?

If you are watching hormone content on Instagram, the most important thing to understand is the difference between treating a diagnosable condition and chasing optimization. These are not the same thing clinically or legally.

Hypogonadism is a real diagnosis with real treatment options. Testosterone cypionate, enanthate, gels, and patches all have FDA approval for men with confirmed hypogonadism. For women, no testosterone product is currently FDA-approved in the US, meaning any female testosterone therapy is off-label. That does not make it wrong, but it does mean the evidence bar should be higher, not lower.

Providers completing functional medicine hormone modules are not automatically practicing outside the standard of care, but they should be transparent with patients about where guideline-based medicine ends and functional medicine extrapolation begins. Patients deserve that distinction. Ask your provider what your actual testosterone level is, whether it meets diagnostic criteria, and what the monitoring plan looks like. Those are not difficult questions, and a good provider will welcome them.